# Lucrin® Depot Efficacy and Safety Monitoring Study in Patients With Advanced Prostate Cancer and Lower Urinary Tract Symptoms (LUTS)

> **NCT01078545** · — · COMPLETED · sponsor: **Abbott** · enrollment: 729 (actual)

## Conditions studied

- Advanced Prostate Cancer
- Lower Urinary Tract Symptoms

## Interventions

- **DRUG:** Leuprolide acetate Depot Susp. 11.25 mg (Poland), 3.75 mg (Ukraine)

## Key facts

- **NCT ID:** NCT01078545
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2010-11
- **Final completion:** 2010-11
- **Target enrollment:** 729 (ACTUAL)
- **Last updated:** 2012-01-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01078545

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01078545, "Lucrin® Depot Efficacy and Safety Monitoring Study in Patients With Advanced Prostate Cancer and Lower Urinary Tract Symptoms (LUTS)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01078545. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*